62.01 0.00 (0.00%)
After hours: 4:06PM EDT
|Bid||61.75 x 1400|
|Ask||64.60 x 800|
|Day's Range||61.48 - 62.30|
|52 Week Range||41.51 - 67.50|
|PE Ratio (TTM)||71.77|
|Earnings Date||Oct 24, 2018 - Oct 29, 2018|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||64.67|
PLAINSBORO, N.J., Aug. 15, 2018-- Integra LifeSciences Holdings Corporation, a leading global medical technology company, will present at the following healthcare conferences in September:. On Thursday, ...
Integra LifeSciences' (IART) progress within its channel expansion strategy and Codman integration buoys investors' optimism on the stock.
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Stocks hitting 52-week highs on July 23) AstraZeneca plc (ADR) (NYSE: AZN )(Sold rights to heart drugs ...
NEW YORK, NY / ACCESSWIRE / July 25, 2018 / Integra LifeSciences Holdings Corporation (NASDAQ: IART ) will be discussing their earnings results in their Q2 Earnings Call to be held on July 25, 2018 at ...
The Plainsboro, New Jersey-based company said it had profit of 14 cents per share. Earnings, adjusted for one-time gains and costs, came to 60 cents per share. The results met Wall Street expectations. ...
Revenue Increased 29.8% to $366.2 million; Organic Revenue Increased 3.4%. Reported EPS of $0.14; Adjusted EPS of $0.60. Raises Low-End of Full-Year Total Revenue and EPS Guidance.
The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Over the last one-month, outflows of investor capital in ETFs holding IART totaled $819 million.
On Friday, July 20, 2018, the NASDAQ Composite, the Dow Jones Industrial Average, and the S&P 500 edged lower at the closing bell. Taking into consideration last Friday's market sentiment, WallStEquities.com assessed the following Medical Instruments & Supplies equities this morning: IsoRay Inc. (NYSE AMER: ISR), STAAR Surgical Co. (NASDAQ: STAA), Conformis Inc. (NASDAQ: CFMS), and Integra LifeSciences Holdings Corp. (NASDAQ: IART).
PLAINSBORO, N.J., July 11, 2018-- Integra LifeSciences Holdings Corporation, a leading global medical technology company, will release second quarter 2018 financial results on Wednesday, July 25, 2018, ...
NEW YORK, June 29, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Applied ...
For today, WallStEquities.com assesses the recent performance of Conformis Inc. (NASDAQ: CFMS), DENTSPLY SIRONA Inc. (NASDAQ: XRAY), Illumina Inc. (NASDAQ: ILMN), and Integra LifeSciences Holdings Corp. (NASDAQ: IART). Companies in the Medical Instruments and Supplies manufacturing industry primarily research, develop, and produce non-electronic medical, surgical, dental, and veterinary instruments and apparatus.
This article is intended for those of you who are at the beginning of your investing journey and want to begin learning the link between Integra LifeSciences Holdings Corporation (NASDAQ:IART)’sRead More...
NEW YORK , May 31, 2018 /PRNewswire/ -- S&P Midcap 400 constituent Westar Energy Inc. (NYSE: WR), to be renamed Evergy, will replace Navient Corp. (NASD: NAVI) in the S&P 500, Navient will replace Westar ...
Integra LifeSciences (IART) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
PLAINSBORO, N.J., May 23, 2018-- Integra LifeSciences Holdings Corporation, a leading global medical technology company, will present at the following healthcare conferences in June:. On Wednesday, June ...
LONDON, UK / ACCESSWIRE / May 16, 2018 / If you want access to our free earnings report on Integra LifeSciences Holdings Corp. (NASDAQ: IART) ("Integra"), all you need to do is sign up now by clicking the following link www.active-investors.com/registration-sg/?symbol=IART. The Company reported its first quarter fiscal 2018 operating and financial results on April 25, 2018. Additionally, the Company raised its revenue and earnings guidance for FY18.
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Stocks hitting 52-week highs on May 9) ABIOMED, Inc. (NASDAQ: ABMD ) Adaptimmune Therapeutics PLC – ...